Monoclonal antibody BTT1023 targeting vascular adhesion protein 1 for treating primary sclerosing cholangitis: BUTEO single-arm Phase II trial

Inter- and Intra-individual Variation, and Limited Prognostic Utility, of Serum Alkaline Phosphatase in a Trial of Patients With Primary Sclerosing Cholangitis

(2020) Palak J. Trivedi et al.   Clinical Gastroenterology and Hepatology

Valuing health-related quality of life: An EQ-5D-5L value set for England

(2017) Nancy J. Devlin et al.   HEALTH ECONOMICS

Myofibroblasts are distinguished from activated skin fibroblasts by the expression of AOC3 and other associated markers

(2016) Lin-ting Hsia et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Surrogate endpoints for clinical trials in primary sclerosing cholangitis: Review and results from an International PSC Study Group consensus process

(2015) Cyriel Y. Ponsioen et al.   HEPATOLOGY

Vascular adhesion protein-1 promotes liver inflammation and drives hepatic fibrosis

(2014) Chris J. Weston et al.   JOURNAL OF CLINICAL INVESTIGATION

Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis

(2013) Kirsten Boonstra et al.   HEPATOLOGY

Primary sclerosing cholangitis

(2013) Gideon M Hirschfield et al.   LANCET

Incidence of primary sclerosing cholangitis: A systematic review and meta-analysis

(2011) Natalie A. Molodecky et al.   HEPATOLOGY

Incidence and prevalence of primary sclerosing cholangitis in a defined adult population in sweden

(2010) Björn Lindkvist et al.   HEPATOLOGY